tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VERA Stock Latest News

Vera Therapeutics price target raised to $90 from $85 at H.C. Wainwright
The FlyVera Therapeutics price target raised to $90 from $85 at H.C. Wainwright
15d ago
VERA
Vera Therapeutics submits BLA for atacicept to FDA
PremiumThe Fly
Vera Therapeutics submits BLA for atacicept to FDA
18d ago
VERA
Vera Therapeutics price target lowered to $52 from $53 at JPMorgan
PremiumThe Fly
Vera Therapeutics price target lowered to $52 from $53 at JPMorgan
18d ago
VERA
Vera Therapeutics’ Atacicept Shows Promising Phase 3 Results and Regulatory Progress, Earning Buy Rating
PremiumRatings
Vera Therapeutics’ Atacicept Shows Promising Phase 3 Results and Regulatory Progress, Earning Buy Rating
19d ago
VERA
Vera Therapeutics Announces Promising Phase 3 Trial Results
PremiumCompany Announcements
Vera Therapeutics Announces Promising Phase 3 Trial Results
19d ago
8K
VERA
Vera Therapeutics reports ‘positive’ data from ORIGIN Phase 3 trial of atacicept
PremiumThe FlyVera Therapeutics reports ‘positive’ data from ORIGIN Phase 3 trial of atacicept
19d ago
VERA
Vera Therapeutics Reports Increased Losses Amid R&D Expansion
Premium
Company Announcements
Vera Therapeutics Reports Increased Losses Amid R&D Expansion
20d ago
VERA
Vera Therapeutics: Strong Financial Position and Promising Pipeline Justify Buy Rating
Premium
Ratings
Vera Therapeutics: Strong Financial Position and Promising Pipeline Justify Buy Rating
20d ago
VERA
Vera Therapeutics reports Q3 EPS ($1.26), consensus ($1.13)
PremiumThe Fly
Vera Therapeutics reports Q3 EPS ($1.26), consensus ($1.13)
20d ago
VERA
Vera Therapeutics Advances Atacicept Study in Autoimmune Kidney Diseases
PremiumCompany Announcements
Vera Therapeutics Advances Atacicept Study in Autoimmune Kidney Diseases
29d ago
VERA
Vera Therapeutics Advances IgAN Treatment with Atacicept Study
PremiumCompany Announcements
Vera Therapeutics Advances IgAN Treatment with Atacicept Study
29d ago
VERA
Vera Therapeutics Advances Atacicept Study for IgAN: Key Insights for Investors
PremiumCompany Announcements
Vera Therapeutics Advances Atacicept Study for IgAN: Key Insights for Investors
29d ago
VERA
Vera Therapeutics initiated with a Buy at BofA
PremiumThe FlyVera Therapeutics initiated with a Buy at BofA
1M ago
VERA
Vera Therapeutics: Buy Rating Backed by Atacicept’s Promising Potential in IgA Nephropathy Treatment
Premium
Ratings
Vera Therapeutics: Buy Rating Backed by Atacicept’s Promising Potential in IgA Nephropathy Treatment
2M ago
VERA
Buy Rating Affirmed for Vera Therapeutics Amid Revised KDIGO Guidelines Boosting IgAN Treatment Market
Premium
Ratings
Buy Rating Affirmed for Vera Therapeutics Amid Revised KDIGO Guidelines Boosting IgAN Treatment Market
2M ago
VERA
KDIGO guidelines positive for Vera Therapeutics, says Cantor Fitzgerald
PremiumThe Fly
KDIGO guidelines positive for Vera Therapeutics, says Cantor Fitzgerald
2M ago
VERA
Vera Therapeutics Reports Progress in Clinical Trials
PremiumCompany Announcements
Vera Therapeutics Reports Progress in Clinical Trials
4M ago
VERA
Vera Therapeutics Signs New Sales Agreement with TD Securities
PremiumCompany Announcements
Vera Therapeutics Signs New Sales Agreement with TD Securities
4M ago
8K
VERA
Vera Therapeutics reports Q2 EPS ($1.20), consensus (62c)
PremiumThe Fly
Vera Therapeutics reports Q2 EPS ($1.20), consensus (62c)
4M ago
VERA
Vera Therapeutics announces anticipated upcoming milestones
PremiumThe FlyVera Therapeutics announces anticipated upcoming milestones
4M ago
VERA
Vera Therapeutics sees cash funding operations through launch of atacicept
Premium
The Fly
Vera Therapeutics sees cash funding operations through launch of atacicept
4M ago
VERA
Tesla grants Musk big payout, Wayfair reports Q2 beat: Morning Buzz
Premium
The Fly
Tesla grants Musk big payout, Wayfair reports Q2 beat: Morning Buzz
4M ago
W
BA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >